Liver regeneration and alcoholic liver disease

被引:36
作者
Lv, Yi [1 ]
So, Kwok Fai [1 ]
Xiao, Jia [1 ,2 ]
机构
[1] Fujian Normal Univ, Coll Life Sci, Lab Neuroendocrinol, Fujian Key Lab Dev & Neurobiol, Fuzhou 350108, Peoples R China
[2] Jinan Univ, Inst Clin Med, Affiliated Hosp 1, Guangzhou 510632, Peoples R China
基金
中国国家自然科学基金;
关键词
liver; regeneration; alcoholic liver diseases (ALD); stem cells; MESENCHYMAL STEM-CELLS; COLONY-STIMULATING FACTOR; SINUSOIDAL ENDOTHELIAL-CELLS; STROMAL CELLS; HEPATITIS; THERAPY; CIRRHOSIS; PROLIFERATION; GENERATION; DIFFERENTIATION;
D O I
10.21037/atm.2020.02.168
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Alcoholic liver diseases (ALD) are a wide spectrum of liver diseases caused by excessive alcohol consumption, from steatosis to cirrhosis. The pathogenesis of ALD is insufficiently understood, but mainly involves oxidative stress, inflammation, bacterial translocation, cell death, and impaired regeneration. Despite numerous attempts to improve patient prognosis, the treatment of advanced ALD is still based on abstinence, brief exposure to corticosteroids, or liver transplantation. However, poor response to corticosteroids and the shortage of liver donors leaves patients helpless towards the end stages. Advances in basic research have contributed to a better understanding of ALD pathophysiology, which offers new options for treatment. In recent years, several therapies related to liver regeneration have been tested with promising prospects, including molecule-induced liver regeneration, stem cell transplantation, and full-function 3D artificial liver assembly. This review discusses mechanisms underlying ALD that can be considered therapeutic targets for regeneration-based treatments.
引用
收藏
页数:12
相关论文
共 81 条
[71]
Mesenchymal stem cells in health and disease [J].
Uccelli, Antonio ;
Moretta, Lorenzo ;
Pistoia, Vito .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (09) :726-736
[72]
Engineered liver for transplantation [J].
Uygun, Basak E. ;
Yarmush, Martin L. .
CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 (05) :893-899
[73]
HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease [J].
Vunjak-Novakovic, Gordana ;
Bhatia, Sangeeta ;
Chen, Christopher ;
Hirschi, Karen .
STEM CELL RESEARCH & THERAPY, 2013, 4
[74]
Nuclear Receptors in Liver Disease [J].
Wagner, Martin ;
Zollner, Gernot ;
Trauner, Michael .
HEPATOLOGY, 2011, 53 (03) :1023-1034
[75]
Simulating Microdosimetry in a Virtual Hepatic Lobule [J].
Wambaugh, John ;
Shah, Imran .
PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (04)
[76]
Mesenchymal stem cells reverse high-fat diet-induced non-alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice [J].
Wang, Huafeng ;
Zhang, Huan ;
Huang, Biao ;
Miao, Guolin ;
Yan, Xiaoyan ;
Gao, Gang ;
Luo, Yongping ;
Chen, Huize ;
Chen, Wei ;
Yang, Luhong .
MOLECULAR MEDICINE REPORTS, 2018, 17 (03) :3769-3774
[77]
Generation of functional hepatocyte-like cells from human bone marrow mesenchymal stem cells by overexpression of transcription factor HNF4α and FOXA2 [J].
Xie, Pei-Yi ;
Hu, Xiao-Jun ;
Guo, Ruo-Mi ;
Meng, Xiao-Chun ;
Pang, Peng-Fei ;
Zhou, Zhi-Yang ;
Li, Dan ;
Shan, Hong .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (06) :546-556
[78]
Key role of liver sinusoidal endothelial cells in liver fibrosis [J].
Xu, Mingxing ;
Wang, Xuehua ;
Zou, Yong ;
Zhong, Yuesi .
BIOSCIENCE TRENDS, 2017, 11 (02) :163-168
[79]
A decade of progress in liver regenerative medicine [J].
Zhang, Jingwei ;
Zhao, Xin ;
Liang, Liguo ;
Li, Jun ;
Demirci, Utkan ;
Wang, ShuQi .
BIOMATERIALS, 2018, 157 :161-176
[80]
Aligned PLLA nanofibrous scaffolds coated with graphene oxide for promoting neural cell growth [J].
Zhang, Kuihua ;
Zheng, Honghao ;
Liang, Su ;
Gao, Changyou .
ACTA BIOMATERIALIA, 2016, 37 :131-142